Related Experiment Videos
Lymphangioma circumscriptum
N R Tulasi1, A John, I Chauhan
1Department of Radiation Oncology, Valavadi Narayanaswamy Cancer Centre, Coimbatore, India. nrtulasi@rediffmail.com
Summary
Lymphangioma circumscriptum (LC) is a rare vulvar complication after pelvic radiotherapy for cervical cancer. Conservative management was successful in two reported cases of this condition.
Area of Science:
- Gynecologic Oncology
- Dermatology
- Radiation Oncology
Background:
- Lymphangioma circumscriptum (LC) is a rare benign vascular tumor.
- Pelvic radiotherapy for cervical cancer is a known risk factor for developing LC of the vulva.
- This condition presents a diagnostic and management challenge in gynecologic oncology.
Observation:
- Two cases of vulvar lymphangioma circumscriptum are presented.
- Both patients had previously undergone pelvic radiotherapy for carcinoma of the cervix.
- The clinical presentation and progression of the lesions were observed.
Findings:
- Vulvar lymphangioma circumscriptum developed as a complication following pelvic radiotherapy.
- Conservative management strategies were employed for both patients.
- The outcomes of conservative management were evaluated.
Implications:
- This report highlights the importance of recognizing vulvar LC as a potential sequela of pelvic radiotherapy.
- Conservative management may be a viable approach for selected cases of vulvar LC post-radiotherapy.
- Further research is warranted to establish optimal treatment guidelines for this rare complication.